Safety and Efficacy of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia

被引：0

作者：

Nicholls, Stephen ^{[1
]}

Nelson, Adam ^{[1
]}

Ditmarsch, Marc ^{[2
]}

Kastelein, John ^{[2
]}

Ballantyne, Christie ^{[3
]}

Ray, Kausik ^{[4
]}

Navar, Ann Marie ^{[5
]}

Nissen, Steven ^{[6
]}

Goldberg, Anne ^{[7
]}

Brunham, Liam ^{[8
]}

Wuerdeman, Erin ^{[9
]}

Neild, Annie ^{[10
]}

Kling, Douglas ^{[11
]}

Hsieh, Andrew ^{[12
]}

Ference, Brian ^{[13
]}

Laufs, Ulrich ^{[14
]}

Banach, Maciej ^{[15
]}

Mehran, Roxana ^{[16
]}

Catapano, Alberico ^{[17
]}

Davidson, Michael ^{[2
]}

机构：

[1] Victorian Heart Hosp, Clayton, Vic, Australia

[2] New Amsterdam Pharma, Amsterdam, Netherlands

[3] Baylor Coll Med, Houston, TX 77030 USA

[4] Imperial Coll London, London, England

[5] UT Southwestern Med Ctr, Dallas, TX USA

[6] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA

[7] Washington Univ, Sch Med, St Louis, MO USA

[8] Univ British C0lumbia, Vancouver, BC, Canada

[9] NewAmsterdam Pharma, Cincinnati, OH USA

[10] NewAmsterdam Pharma, Aventura, FL USA

[11] NewAmsterdam Pharma, Lebanon, NJ USA

[12] Univ Illinois, Long Grove, IL USA

[13] Deep Causal AI, Cambridge, England

[14] Univ Clin Leipzig, Leipzig, Germany

[15] Med Univ Lodz, Lodz, Poland

[16] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[17] Univ Milan, Milan, Italy

来源：

CIRCULATION | 2024年 / 150卷 / 25期

关键词：

CETP inhibitors; Lipids; Clinical trials; Dyslipidemia; Prevention;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4171281

引用

页码：E729 / E730

页数：2

共 50 条

[31] Colesevelam: In pediatric patients with heterozygous familial hypercholesterolemia
Perry C.M.
Pediatric Drugs, 2010, 12 (2) : 133 - 140
[32] Efficacy and Safety of Ongericimab in Chinese Patients With Homozygous Familial Hypercholesterolemia
Lin, Jie
Chen, Jiyan
Zhang, Ruiyan
Wang, Jingfeng
Bai, Xuelian
Yan, Hui
Yu, Jianjun
Yao, Sheng
Feng, Hui
Lin, Jie
CIRCULATION, 2022, 146
[33] Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia
Harada-Shiba, Mariko
Ikewaki, Katsunori
Nohara, Atsushi
Otsubo, Yoshihiko
Yanagi, Koji
Yoshida, Masayuki
Chang, Qing
Foulds, Pamela
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (04) : 402 - 411
[34] SAFETY AND EFFICACY OF LONG-TERM HYPOCHOLESTEROLEMIC REGIMENS IN 73 CHILDREN HETEROZYGOUS FOR FAMILIAL HYPERCHOLESTEROLEMIA
GLUECK, CJ
MELLIES, MJ
DINE, M
PERRY, T
LASKARZEWSKI, P
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1986, 43 (04): : 700 - 700
[35] SAFETY AND EFFICACY OF LONG-TERM HYPOCHOLESTEROLEMIC REGIMENS IN 73 CHILDREN HETEROZYGOUS FOR FAMILIAL HYPERCHOLESTEROLEMIA
GLUECK, CJ
MELLIES, MJ
DINE, M
PERRY, T
LASKARZEWSKI, P
CLINICAL RESEARCH, 1986, 34 (02): : A796 - A796
[36] Safety and Efficacy of Inclisiran in Patients With Heterozygous Familial Hypercholesterolemia - Results From the Phase 3 ORION-9 Trial
Raal, Frederick J.
Ray, Kausik K.
Kallend, David
Koenig, Wolfgang
Wright, R. Scott
Leiter, Lawrence A.
Wijngaard, Peter L.
Kastelein, Johannes J., Jr.
CIRCULATION, 2019, 140 (25) : E987 - E987
[37] Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study
Gaudet, Daniel
Langslet, Gisle
Gidding, Samuel S.
Luirink, Ilse K.
Ruzza, Andrea
Kurtz, Christopher
Lu, Chen
Somaratne, Ransi
Raal, Frederick J.
Wiegman, Albert
JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (05) : 1199 - 1207
[38] REMARKABLE EFFICACY OF BEMPEDOIC ACID IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH)
Agha, Ali
Jones, Peter
Ballantyne, Christie
Virani, Salim
Nambi, Vijay
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 2780 - 2780
[39] EFFICACY AND SAFETY OF EZETIMIBE MONOTHERAPY IN CHILDREN SIX TO TEN YEARS OF AGE WITH HETEROZYGOUS FAMILIAL OR NON-FAMILIAL HYPERCHOLESTEROLEMIA
Kastelein, John J. P.
Kusters, Meeike
Caceres, Maria
Coll, Mauricio
Cuffie, Cynthia
Gagne, Claude
Jacobson, Marc
Kwiterovich, Peter
Lee, Raymond
Lowe, Robert
Massaad, Rachid
McCrindle, Brian
Musliner, Thomas
Triscari, Joseph
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1466 - E1466
[40] When should patients with heterozygous familial hypercholesterolemia be treated?
Rifkind, BM
Schucker, B
Gordon, DJ
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (02): : 180 - 181

← 1 2 3 4 5 →